The economic burden extends beyond medical costs, impacting work productivity.<h4>Materials and methods</h4>Chinese patients with YOD were recruited between June 2023 and April 2024 in the Precision Medicine to redefine Insulin Secretion and Monogenic diabetes Trial in Hong Kong (NCT04049149). This evidence concerns the gene INS and diabetes mellitus.